| Literature DB >> 32879885 |
Chao Ma1, Xuefeng Luo1, Wuluhan Mahan1, Yahui Tang2, Yun Duan1, Rui Mao3, Zengru Xie1.
Abstract
BACKGROUND: Osseous cyst echinococcosis (CE) is an infectious disease that causes disability and deformity in patients, yet there is still no satisfactory treatment. Focusing on the feasibility and prognosis of radiotherapy as an adjuvant or palliative treatment for osseous CE, this study investigated the outcome of Meriones meridianus with osseous CE after radiotherapy.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32879885 PMCID: PMC7448241 DOI: 10.1155/2020/6457419
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Number of dead gerbils and number of lesion sites with ulceration and infection (n = 40), comparison between groups (mean ± standard deviation).
| Group | Number of dead gerbils | Number of lesion sites with ulceration and infectiona | ||||||
|---|---|---|---|---|---|---|---|---|
| 3 months | 6 months |
|
| 3 months | 6 months |
|
| |
| Control group | 11 | 20 | 4.27 | 0.04 | 9 | 13 | 5.52 | 0.02 |
| 40Gy/5times group | 5 | 13 | 4.59 | 0.03 | 5 | 10 | 4.30 | 0.04 |
| 50Gy/5times group | 1∗ | 3∗∗# | 1.05 | 0.31 | 2∗ | 3∗∗# | 0.27 | 0.60 |
|
| 10.4 | 17.4 | 8.57 | 20.35 | ||||
|
| 0.005 | <0.001 | 0.01 | <0.001 | ||||
aDead gerbils were not counted. The chi-squared test and Bonferroni correction were used to detect the differences between groups. ∗P < 0.01 vs. control group; ∗∗P < 0.001 vs. control group; #P < 0.01 vs. 40Gy/5times group.
Number of dead scolices (n = 15), comparison between groups (mean ± standard deviation).
| Group | Number of dead scolices | |||
|---|---|---|---|---|
| 3 months | 6 months |
|
| |
| Control group | 22.40 ± 3.11 | 23.20 ± 2.24 | 0.238 | 0.626 |
| 40Gy/5times group | 95.0 ± 5.22∗∗ | 98.20 ± 4.60∗∗ | 1.538 | 0.215 |
| 50Gy/5times group | 135.53 ± 5.44∗∗## | 169.33 ± 7.02∗∗## | 236.34 | <0.001 |
|
| 2021.032 | 3207.05 | ||
|
| <0.001 | <0.001 | ||
The chi-squared test and Bonferroni correction were used to detect the differences between groups. ∗∗P < 0.001 vs. control group; ##P < 0.001 vs. 40Gy/5times group.
Protein content andCa2+ concentration (n = 15), comparison between groups (mean ± standard deviation).
| Group | Protein content (g/L) | Ca2+ concentration (mmol/L) | ||||||
|---|---|---|---|---|---|---|---|---|
| 3 months | 6 months |
|
| 3 months | 6 months |
|
| |
| Control group | 1.059 ± 0.055 | 1.088 ± 0.043 | -1.58 | 0.12 | 2.802 ± 0.157 | 2.804 ± 0.019 | -0.05 | 0.96 |
| 40Gy/5times group | 0.733 ± 0.051∗∗ | 0.753 ± 0.034∗∗ | -1.26 | 0.22 | 3.056 ± 0.060∗∗ | 3.068 ± 0.052∗∗ | -0.58 | 0.57 |
| 50Gy/5times group | 0.571 ± 0.043∗∗## | 0.340 ± 0.032∗∗## | 16.68 | <0.001 | 3.546 ± 0.135∗∗## | 3.886 ± 0.046∗∗## | -9.21 | <0.001 |
|
| 372.90 | 1516.61 | 138.11 | 2737.03 | ||||
|
| <0.001 | <0.001 | <0.001 | <0.001 | ||||
Student's unpaired t-test and one-way analysis of variance (ANOVA) with LSD post hoc test were used to detect the differences between groups. ∗∗P < 0.001 vs. control group; ##P < 0.001 vs. 40Gy/5times group.
Maximum diameter of lesion site and wet weight of cyst (n = 15), comparison between groups (mean ± standard deviation).
| Group | Maximum diameter of lesion site (cm) | Wet weight of cyst (g) | ||||||
|---|---|---|---|---|---|---|---|---|
| 3 months | 6 months |
|
| 3 months | 6 months |
|
| |
| Control group | 2.38 ± 0.14 | 2.652 ± 0.05 | -7.02 | <0.001 | 3.47 ± 0.11 | 3.75 ± 0.31 | -3.28 | 0.003 |
| 40Gy/5times group | 1.69 ± 0.05∗∗ | 1.69 ± 0.03∗∗ | 0.09 | 0.93 | 2.54 ± 0.12∗∗ | 2.55 ± 0.08∗∗ | -0.27 | 0.79 |
| 50Gy/5times group | 1.40 ± 0.09∗∗## | 1.03 ± 0.06∗∗## | 12.90 | <0.001 | 1.46 ± 0.07∗∗## | 1.02 ± 0.20∗∗## | 8.01 | <0.001 |
|
| 372.83 | 4216.38 | 1433.46 | 5858.86 | ||||
|
| <0.001 | <0.001 | <0.001 | <0.001 | ||||
Student's unpaired t-test and one-way analysis of variance (ANOVA) with LSD post hoc test were used to detect the differences between groups. ∗∗P < 0.001 vs. control group; ##P < 0.001 vs. 40Gy/5times group.
Figure 1The rate of cyst inhibition. (a, b) The inhibition rate between 40Gy/5times (50Gy/5times) and control groups at 3 months. (c, d) The inhibition rate between 40Gy/5times (50Gy/5times) and control groups at 6 months. (e, f, g) Within-group inhibition rate of the control group, 40Gy/5times group, and 50Gy/5times group.
Figure 2Pathological section of lesion sites. (a, b) The control group at 3 and 6 months. (c, d) The 40Gy/5times group at 3 and 6 months. (e, f) The 50Gy/5times group at 3 and 6 months.